Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2025 07:30 ET | Source: Yiviva

Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025

YIV-906, in combination with sorafenib, shows promising Phase 2b results for advanced liver cancer, enhancing efficacy and reducing toxicity.